ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.


Hierarchy:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Dihydropyridines ∟ Nicardipine 9 coordinate concepts ∟ 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester \| ∟ Amlodipine \| ∟ Dicarbethoxydihydrocollidine \| ∟ Felodipine \| ∟ Isradipine \| ∟ Nifedipine \| ∟ Nimodipine \| ∟ Nisoldipine \| ∟ Nitrendipine X
Broader terms:	Medical Subject Headings (MeSH) ∟ Heterocyclic Compounds ∟ Heterocyclic Compounds, 1-Ring ∟ Pyridines ∟ Dihydropyridines ∟ Nicardipine Dihydropyridines > Pyridines > Heterocyclic Compounds, 1-Ring > Heterocyclic Compounds > Medical Subject Headings (MeSH) X
History note:	Nifedipine/analogs & derivatives (1975-1986) \| Pyridines (1966-1974)X
historyNote*:	87 X
publicMeSHNote*:	87 X
Scope note:	A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. X
activeMeSHYear*:	2005 \| 2006 \| 2007X
dateCreated*:	1986-06-02X
dateEstablished*:	1987-01-01X
dateRevised*:	2004-07-07X
recordAuthorizer*:	sjnX
recordMaintainer*:	lkwX
recordOriginator*:	RLSX
Type:	Concept X
Coordinate terms:	3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester \| Amlodipine \| Dicarbethoxydihydrocollidine \| Felodipine \| Isradipine \| Nifedipine \| Nimodipine \| Nisoldipine \| Nitrendipine X
URI:	X
Labels and equivalent concepts:	Nikardipiini (fi) Nikardipin (sv) UCB Brand of Nicardipine Hydrochloride (en, replaced) Tedec Meiji Brand of Nicardipine Hydrochloride (en, replaced) Syntex Brand of Nicardipine Hydrochloride (en, replaced) Vasonase (en, replaced) Yamanouchi Brand 1 of Nicardipine Hydrochloride (en, replaced) Yamanouchi Brand 3 of Nicardipine Hydrochloride (en, replaced) Yamanouchi Brand 2 of Nicardipine Hydrochloride (en, replaced) Solvay Brand of Nicardipine Hydrochloride (en, replaced) Seid Brand of Nicardipine (en, replaced) ESP Pharma Brand of Nicardipine Hydrochloride (en, replaced) Antagonil (en, replaced) Farma Lepori Brand of Nicardipine Hydrochloride (en, replaced) Novartis Brand of Nicardipine Hydrochloride (en, replaced) Roche Brand of Nicardipine Hydrochloride (en, replaced) Ratiopharm Brand of Nicardipine Hydrochloride (en, replaced) Almirall Brand of Nicardipine Hydrochloride (en, replaced) X
Share:	X